A Risk Assessment Tool for Resumption of Research Activities During the COVID-19 Pandemic.
Suzanne M SimkovichLisa M ThompsonMaggie ClarkKalpana BalakrishnanAlejandra BussalleuWilliam CheckleyThomas ClasenVictor Davila-RomanAnaite Diaz-ArtigaLisa de Las FuentesSteven HarveyMiles KirbyAmy LovvornEric McCollumJennifer PeelAshlinn QuinnGhislaine RosaLindsay UnderhillKendra WilliamsBonnie YoungJoshua RosenthalPublished in: Research square (2020)
By applying a systematic, procedure-specific approach to risk assessment for each trial activity, we can compare trial activities using the same criteria. This approach allows us to protect our participants and research team and to uphold our ability to deliver on the research commitments we have made to our participants, local communities, and funders. The trial is registered with clinicaltrials.gov (NCT02944682).